CRÉDIT AGRICOLE CIB FINANCIAL SOLUTIONS | Market Closed - Börse Stuttgart 06:11:28 2024-07-11 am EDT | ||
| 98.91 USD | +0.17% |
|
| Current month | +0.20% | ||
| 1 month | +0.15% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 98.91 | +0.17% |
| 24-07-10 | 98.74 | +0.45% |
| 24-07-09 | 98.3 | +0.20% |
| 24-07-08 | 98.1 | -0.26% |
| 24-07-05 | 98.36 | +0.45% |
Delayed Quote Börse Stuttgart
Last update July 11, 2024 at 06:11 am EDT
More quotesStatic data
| Product type | Certificati Altri |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | Crédit Agricole |
| WKN | A4AEGA |
| ISIN | XS2638710819 |
| Date issued | 2024-01-24 |
| Strike | 49.98 $ |
| Maturity | 2025-01-17 (190 Days) |
| Parity | 0.05 : 1 |
| Emission price | 100 $ |
| Emission volume | N/A |
| Settlement | entrambi |
| Currency | USD |
Technical Indicators
| Highest since issue | 101.7 $ |
|---|---|
| Lowest since issue | 96.94 $ |
| Spread | 5 $ |
| Spread % | 0.50% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
40.75
USD
Average target price
52.92
USD
Spread / Average Target
+29.87%
- Stock Market
- Certificates
- Certificat
